We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
Cap. Flow
-$469M
Cap. Flow %
-3.86%
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$38.7M
2
AAPL icon
Apple
AAPL
+$27.7M
3
CRM icon
Salesforce
CRM
+$26.1M
4
VZ icon
Verizon
VZ
+$25.9M
5
PEP icon
PepsiCo
PEP
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Technology 24.24%
3 Financials 8.36%
4 Communication Services 6.82%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$622M 5.12%
2,421,274
-241,956
-9% -$65.7M
AAPL icon
2
Apple
AAPL
$4.81T
$436M 3.59%
3,188,623
+182,945
+6% +$27.7M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$387M 3.19%
3,554,140
-160,060
-4% -$18.8M
MRK icon
4
Merck
MRK
$312B
$317M 2.61%
3,482,038
-58,091
-2% -$5.15M
AMGN icon
5
Amgen
AMGN
$198B
$228M 1.88%
935,915
+2,182
+0.2% +$535K
DHR icon
6
Danaher
DHR
$127B
$225M 1.86%
1,002,614
+55,036
+6% +$12.7M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$70.8B
$220M 1.81%
372,793
+3,503
+0.9% +$2.28M
TMO icon
8
Thermo Fisher Scientific
TMO
$195B
$220M 1.81%
404,266
+20,224
+5% +$11.1M
PG icon
9
Procter & Gamble
PG
$345B
$203M 1.67%
1,410,408
+257,733
+22% +$38.7M
UNH icon
10
UnitedHealth
UNH
$396B
$200M 1.65%
389,456
+33,073
+9% +$16.6M
LLY icon
11
Eli Lilly
LLY
$1.05T
$156M 1.28%
480,709
-109,753
-19% -$32.9M
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$138M 1.13%
778,045
-107,831
-12% -$15.5M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$122B
$132M 1.09%
467,883
-6,370
-1% -$1.7M
GILD icon
14
Gilead Sciences
GILD
$162B
$125M 1.03%
2,030,259
+281,973
+16% +$17.5M
V icon
15
Visa
V
$677B
$115M 0.95%
585,595
+74,170
+15% +$15.3M
JNJ icon
16
Johnson & Johnson
JNJ
$603B
$114M 0.94%
641,771
-229,897
-26% -$41M
AMZN icon
17
Amazon
AMZN
$2.66T
$102M 0.84%
960,320
-155,540
-14% -$19.5M
ADBE icon
18
Adobe
ADBE
$90.3B
$102M 0.84%
277,923
-67,159
-19% -$27.3M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.22T
$101M 0.83%
923,860
-161,840
-15% -$19.1M
NVDA icon
20
NVIDIA
NVDA
$5.02T
$98.1M 0.81%
6,469,140
+219,310
+4% +$4.14M
DIS icon
21
Walt Disney
DIS
$167B
$94.3M 0.78%
998,600
-288,947
-22% -$32.1M
TSLA icon
22
Tesla
TSLA
$1.42T
$94.1M 0.77%
419,079
+45,084
+12% +$12.3M
BAC icon
23
Bank of America
BAC
$430B
$91.6M 0.75%
2,942,332
+468,679
+19% +$16.9M
ABT icon
24
Abbott
ABT
$174B
$91.6M 0.75%
842,962
+30,372
+4% +$3.45M
SQM icon
25
Sociedad Química y Minera de Chile
SQM
$19.7B
$90.9M 0.75%
1,088,038
-665,550
-38% -$58.6M

Similar funds

Candriam SCA's Q2 2022 Portfolio in Review

As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.

  • Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
  • Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
  • Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
  • Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
  • Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
  • Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
  • Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.